Navigation Links
Insmed Announces First Quarter 2008 Financial Results
Date:5/8/2008

RICHMOND, Va., May 8 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM), a developer of follow-on biologics (FOB) and biopharmaceuticals, today reported results for the first quarter ended March 31, 2008.

Recent Company Highlights

-- Follow-on Biologics Program

-- Received regulatory approval from the United Kingdom's Medicines and

Healthcare products Regulatory Agency to initiate a clinical trial

for Insmed's most advanced FOB candidate, INS-19 (Granulocyte Colony

Stimulating Factor or G-CSF), a FOB of the FDA-approved product

Neupogen(R), which had U.S. sales of approximately $0.9 billion in

2007;

-- Received and completed questionnaire from the Chairman and Ranking

Member of the U.S. House of Representatives' Subcommittee on Health

on the possible development of legislation to establish a FOB

regulatory pathway and;

-- Participated in two FOB-focused events: the Center for Business

Intelligence's "Evaluate the Legislative, Economic and Scientific

Implications of the Industry Debate on: Biosimilars and Follow-On

Biologics", and the American Enterprise Institute Follow-On

Biologics Program.

-- IPLEX(TM)

-- All sites have been initiated, received Investigational Review Board

approvals and are actively recruiting trial participants in the

Phase 2 clinical trial for IPLEX(TM) in Myotonic Muscular Dystrophy

("MMD"). The trial presently has 50% of the required 60 patients

enrolled and:

-- Received $2.3 million in cost recovery revenue in the first quarter

related to the expanded access program ("EAP") for IPLEX(TM) in

Italy to treat patients with Amyotrophic Lateral Sclerosis ("ALS"),

also known as Lou Gehrig's Disease. The EAP currently includes 20

phys
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Insmed Appoints Dennis M. Lanfear to Board Of Directors
2. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
3. Insmed to Appeal Delisting Notification From Nasdaq
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
6. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
7. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
8. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
9. Insmed Announces Additional Information in Compliance With NASDAQ Rules
10. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
11. Insmed to Present at CBI Follow-On Biologics Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), a biopharmaceutical ... innovative therapeutics addressing cancer and other unmet medical needs ... China , today reported financial results ... 2014.  The Company reported a net ... the three months ended December 31, 2014.  This compares ...
(Date:3/26/2015)... San Bruno, CA (PRWEB) March 26, 2015 ... organization (CRO), announced today several management and executive ... role of Chief Financial Officer (CFO) and member of ... Vice President of Business Operations, and Sue Dowden will ... Tony Taricco, co-founder and current Chief Operations Officer (COO), ...
(Date:3/26/2015)... March 26, 2015  BioNano Genomics, Inc., the leader ... Salyer as chief commercial officer. Salyer has more ... sales teams in life sciences. At BioNano, Salyer will ... a genome-mapping platform to assemble a comprehensive view of ... To date, 32 institutions located in the ...
(Date:3/26/2015)... March 26, 2015 PAREXEL International ... clinical research organization , announced today ... agreement to acquire all of the business ... leading provider of specialized pharmacovigilance services, based ... collection, detection, assessment, monitoring, and prevention of ...
Breaking Biology Technology:CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 2PRC Clinical Announces Key Management Appointments and Launches East Coast Operations 3BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 2BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 3PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 2PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 3PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 4
... DIEGO, Dec. 4 Vical Incorporated (Nasdaq:,VICL) ... restructured website at, http://www.vical.com . The site ... to recent and upcoming webcasts, technology and ... management,information, and other data of interest to ...
... Imatinib (marketed as Gleevec in the US and Glivec ... cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal ... two distinct types of cancer because they are caused ... of specificity for a single protein means that imatinib ...
... pathway that powers sperm to swim long distances could ... mechanical functions inside the body, according to a presentation ... meeting. , The work by researchers at Cornells ... demonstration of how multistep biological pathways can be assembled ...
Cached Biology Technology:Vical Launches Redesigned Website 2Tethered to chip, energy supply that drives sperm could power 'nanobot' 2
(Date:3/2/2015)...   Neurotechnology , a provider of high-precision biometric, ... Software Development Kit (SDK). The SentiGaze algorithm enables ... webcams to track eye movements and generate heatmaps based ... can be used for applications such as analysis of ... SDK can also be used to develop interfaces for ...
(Date:2/24/2015)... This report analyzes the worldwide markets for Iris Biometrics in ... US, Canada , Japan ... , Middle East , and ... for the period 2013 through 2020. Also, a seven-year historic ... are derived from primary and secondary research. Company profiles are ...
(Date:2/24/2015)... 2015 Research and Markets ( ... "Global 2D Gesture Recognition Market 2015-2019" ... analysts forecast the Global 2D Gesture Recognition market ... the period 2014-2019 The increased demand ... one of the major trends in the market. ...
Breaking Biology News(10 mins):Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2
... Hikers know that moss on a tree trunk always points ... this ancient plant may also provide a new "compass" for ... cells for medical purposes. Dr. Nir Ohad ... Ralf Reski of the University of Freiburg have discovered a ...
... You can learn a lot from an animal. By ... have discovered a great deal about the genes and molecules ... work about the same in people as they do in ... cognitive processes such as humans, ability to learn language from ...
... main objective of the research was to gather information on ... the hydrological and dynamic characteristics of plankton in the estuaries. ... and his work entitled Impact of climate variability on the ... (Bay of Biscay): a time series analysis. He has studied ...
Cached Biology News:Telltale moss 2Transgenic songbirds provide new tool to understand the brain 2University of Basque Country research study on effects of climate on plankton in the estuaries 2
... is essential for hunting and analyzing ... such as EST sequencing projects, microarrays, ... kit is developed for normalization of ... intended for directional cloning. While most ...
Peptide-affinity Purified Polyclonal Antibody to ICEBERG Peptide with sequence EEDPQLASKMGLH, from C Terminus of the protein sequence according to NP_067546...
Purified anti-Fanconi anemia D2-Phosphorylated (Ser222)...
Peptide-affinity Purified Polyclonal Antibody to Olfactory Receptor, Family 2, Subfamily H, Member 3...
Biology Products: